| N-succinimidyl 4-fluorobenzoate (SFB) | protein, nanoparticle labeling |
| p-fluorobenzaldehyde | protein, nanoparticle labeling |
| fluoroethyltosylate | fluoroethylation |
| fluoromethyltosylate | fluoromethylation |
| 6-Fluoro-6-deoxyglucose | glucose transport |
| 5HTT | serotonin transporter ligand |
| Anginex | angiogenesis, tumor assessment |
| Annexin V | apoptosis |
| Antibodies | custom labeled antibody imaging |
| Nanoparticles | custom labeled nanoparticles microbubbles, liposomes |
| 9-[(18)F]fluoropropyl-(+)-dihydrotetrabenazine | VMAT2 |
| AV-45 | amyloid plaque |
| Avastin/Bevacizumab | chemotherapeutic, Angiogenesis |
| Fluorocarazolol | beta-adrenergic, quantitative tracer |
| fluorobenzaldehyde dansylhydrazone | apoptosis |
| fluorocholine | prostate cancer |
| Fluoroethyldiprenorphine | opiate receptors (antagonist) |
| 2-Fluoro-2-deoxyglucose | glucose metabolic rate |
| FEPPA | Translocator protein (PBR) see PK11195 |
| 17-betafluoroestradiol | estrogen receptors |
| Fluoroethylcholine | prostate cancer |
| Fluorohydroxybenzylguanidine | reporter gene (v-TK) |
| Fluoride | Bone scans |
| Fluorothymidine | cell proliferation |
| Fluoromethane | perfusion (any, but most often cerebral) |
| Fluoromisonidazole | hypoxia |
| FluoromethylNER-D(2) | Norepinephrine transporter |
| 16-fluoroPalmitoyl ethanolamide | FAAH activity |
| Fluoroethylspiperone | dopamine and serotonin receptor |
| WC-II-89 | caspase inhibitor, apoptosis imaging |
